8 completed, 1 active not recruiting, 1 terminated. 10 Phase 2, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 8, Active not recruiting 1, Terminated 1 |
| Phase 3 | 6 | Completed 5, Active not recruiting 1 |
Follow Allergic Bronchopulmonary Aspergillosis: new trials by email Literature Review of Allergic Bronchopulmonary Aspergillosis trials Research Report on Allergic Bronchopulmonary Aspergillosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) - Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis | Phase 2 | Completed | Radboud University Medical Center | 10 | 2025-05-01 | 2026-08-18 |
| Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) dupilumab, Placebo - Allergic Bronchopulmonary Aspergillosis | Phase 2 | Completed | Regeneron Pharmaceuticals | 62 | 2020-09-15 | 2025-04-04 |
| Deflazacort Vs. Prednisolone in Acute-stage ABPA Deflazacort, Prednisolone - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Active not recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 150 | 2020-01-15 | 2025-02-28 |
| Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis PUR1900, Placebo - Allergic Bronchopulmonary Aspergillosis | Phase 2 | Terminated | Pulmatrix Inc. | 7 | 2019-07-31 | 2021-08-27 |
| Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded). Liposomal amphotericin B (Ambisome®), placebo - Allergic Bronchopulmonary Aspergillosis | Phase 2 | Completed | Poitiers University Hospital | 174 | 2014-11-19 | 2020-06-09 |
| A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis Itraconazole, Glucocorticoids - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 191 | 2014-05-01 | 2022-10-07 |
| Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis Prednisolone, Voriconazole - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 50 | 2013-06-01 | 2017-12-12 |
| A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis Inhaled budesonide, Inhaled amphotericin - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 21 | 2013-05-01 | 2015-08-05 |
| Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis Glucocorticoids, Itraconazole - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 100 | 2011-04-01 | 2017-03-16 |
| Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis Glucocorticoids - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 92 | 2009-04-01 | 2015-02-24 |
Aspergillosis, Allergic Bronchopulmonary (10) · Asthma (2) · Aspergillosis (1) · Pulmonary Aspergillosis (1)
Bacterial Infections and Mycoses (10) · Hypersensitivity (10) · Hypersensitivity, Immediate (10) · Immune System Diseases (10) · Infections (10) · Lung Diseases (10) · Lung Diseases, Fungal (10) · Mycoses (10) · Respiratory Hypersensitivity (10) · Respiratory Tract Diseases (10) · Respiratory Tract Infections (10) · Aspergillosis (9) · Pulmonary Aspergillosis (9) · Bronchial Diseases (2) · Lung Diseases, Obstructive (2)
Glucocorticoids (3) · Prednisolone (3) · Azoles (2) · Itraconazole (2) · Steroids (1) · Voriconazole (1) · deflazacort (1) · dupilumab (1) · liposomal amphotericin B (1)
Post Graduate Institute of Medical Education and Research, Chandigarh (6) · Poitiers University Hospital (1) · Pulmatrix Inc. (1) · Radboud University Medical Center (1) · Regeneron Pharmaceuticals (1)
India (7) · France (2) · Netherlands (2) · Poland (2) · United Kingdom (2) · United States (2) · Australia (1) · Bulgaria (1) · Germany (1) · Hungary (1) · Japan (1) · Romania (1)
Ritesh Agarwal, MD, DM (2) · David Denning, FRCP, FRC Path, FIDSA, FMedSci (1) · William J. Calhoun, MD (1)
PMID 26585431, PMID 29331473, PMID 30049743, PMID 33027187, PMID 34764182, PMID 38387646, PMID 42845221
2019 (1), 2023 (1)